Pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies; Pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies by restoring mitochondrial health via pathways that regulate mitochondrial and organelle dynamics

'diseas':7,17 'dynam':32 'health':24 'mitochondri':23,29 'neurodegen':6,16 'neuropathi':10,20 'organell':31 'pathway':26 'peripher':9,19 'pharmaceut':1,11 'regul':28 'restor':22 'treatment':4,14 'via':25

Pharmaceutical research and development; Research and development of pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies; Research and development of pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies by restoring mitochondrial health via pathways that regulate mitochondrial and organelle dynamics

'develop':4,7,21 'diseas':15,29 'dynam':44 'health':36 'mitochondri':35,41 'neurodegen':14,28 'neuropathi':18,32 'organell':43 'pathway':38 'peripher':17,31 'pharmaceut':1,9,23 'regul':40 'research':2,5,19 'restor':34 'treatment':12,26 'via':37

MOTYL THERAPEUTICS

Owner

Goods & Services